Samrat Pharma

16
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
228.10
-2.7 (-1.17%)
BSENSE

Dec 19

BSE+NSE Vol: 648

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024

Compare Profit and Loss Results of Samrat Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
285.00
44.00
241.00
547.73%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
285.00
44.00
241.00
547.73%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
5.00
-7.00
-140.00%
Raw Materials Consumed
269.00
33.00
236.00
715.15%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
2.00
15.00
-13.00
-86.67%
Operating Expenses
2.00
3.00
-1.00
-33.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
275.00
63.00
212.00
336.51%
Operating Profit (PBDIT) excl Other Income
10.00
-18.00
28.00
155.56%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
11.00
-15.00
26.00
173.33%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
10.00
-22.00
32.00
145.45%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
9.00
-22.00
31.00
140.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
-22.00
31.00
140.91%
Provision for Tax
2.00
-5.00
7.00
140.00%
Profit After Tax
7.00
-17.00
24.00
141.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
61.00
-49.00
110.00
224.49%
Profit Available for appropriations
69.00
-66.00
135.00
204.55%
Appropriations
69.00
-66.00
135.00
204.55%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
23.02
-3.95
26.97
682.78%
Profit And Loss - Net Sales
Net Sales 285.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024

Profit And Loss - Interest
Interest 0.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024